Drug class in one race
ROS1 drugs for Non-Small Cell Lung Cancer
3 tracked ROS1 drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the ROS1 page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
2 approved / phase 41 Phase 3